Increased Expression of Serine Palmitoyltransferase (SPT) in Balloon-injured Rat Carotid Artery

Summary

The response to vascular injury is a complex wound healing response involving cell proliferation, migration, remodeling and inflammation. In the present studies we employed a rat balloon angioplasty model of vascular injury to investigate the potential role of sphingolipid signaling in the response to vascular injury. The enzyme serine palmitoyltransferase (SPT) catalyzes the first committed step in de novo sphingolipid biosynthesis. We observed marked upregulation of expression of both SPT subunits in actively proliferating cells in injured vessels. This enhanced SPT expression occurs in de-differentiated fibroblasts and proliferating vascular smooth muscle cells. The upregulation is particularly apparent in the proliferating luminal edge of the neointima and the adventitial de-differentiated fibroblasts and may serve as a hallmark of this process. The possible functional consequences of this enzyme upregulation and its role in the response to vascular injury are suggested but remain to be determined.

Keywords

Serine palmitoyltransferase -1 and -2 - rat balloon angioplasty - restenosis - immunohistochemistry - reactive fibroblasts

• References

• 1 Hannun YA, Bell RM. Functions o sphingolipids and sphingolipid breakdown products in cellular regulation [see comments]. Science 1989; 243 4890 500-7.
• 2 Merrill Jr AH. Hannun YA, Bell RM Introduction: sphingolipids and their metabolites in cell regulation. Adv Lipid Res 1993; 25: 1-24.
• 3 Kolesnick R. Signal transduction through the sphingomyelin pathway. Mol Chem Neuropathol 1994; 21 2-3 287-97.
• 4 Williams RD, Wang E, Merrill Jr AH. Enzymology of long-chain base synthesis by liver: characterization of serine palmitoyltransferase in rat liver microsomes. Archives of Biochemistry & Biophysics 1984; 228 (Suppl. 01) 282-91.
• 5 Spiegel S, Frost D, Kolesnick R. Signal transduction through lipid second messengers. Current Opinions in Cell Biology 1996; 8: 159-67.
• 6 Hannun YA. The sphingomyelin cycle and the second messenger function of ceramide. J Biol Chem 1994; 269 (Suppl. 05) 3125-8.
• 7 > Bose R, Verheij M, Haimovitz-Friedman A, Scotto K, Fuks Z, Kolesnick R. Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals. Cell 1995; 82 (Suppl. 03) 405-14.
• 8 Perry DK, Hannun YA. The role of ceramide in cell signaling. Biochim Biophys Acta 1998; 1436 1-2 233-43.
• 9 Spiegel S, Merrill Jr AH. Sphingolipid metabolism and cell growth regulation. Faseb J 1996; 10 (Suppl. 12) 1388-97.
• 10 Ancellin N, Hla T. Differential pharmacological properties and signal transduction of the sphingosine 1-phosphate receptors EDG-1, EDG-3, and EDG-5. J Biol Chem 1999; 274 (Suppl. 27) 18997-9002.
• 11 Lee MJ, Van Brocklyn JR, Thangada S, Liu CH, Hand AR, Menzeleev R. et al. Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1. Science 1998; 279 5356 1552-5.
• 12 van Brocklyn JR, Graler MH, Bernhardt G, Hobson JP, Lipp M, Spiegel S. Sphingosine-1-phosphate is a ligand for the G protein-coupled receptor EDG-6. Blood 2000; 95 (Suppl. 08) 2624-9.
• 13 Wang F, Van Brocklyn JR, Hobson JP, Movafagh S, Zukowska-Grojec Z, Milstien S. et al. Sphingosine 1-phosphate stimulates cell migration through a G(i)-coupled cell surface receptor. Potential involvement in angiogenesis. J Biol Chem 1999; 274 (Suppl. 50) 35343-50.
• 14 Schwartz RS. The vessel wall reaction in restenosis. Semin Interv Cardiol 1997; 2 (Suppl. 02) 83-8.
• 15 Clowes AW, Reidy MA, Clowes MM. Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. Laboratory Investigation Field Publication Date: Sep 1983; 49 (Suppl. 03) 327-33. Field Reference Number. Field Journal Code: KZ4 Field Call Number:
• 16 Clowes AW, Reidy MA, Clowes MM. Mechanisms of stenosis after arterial injury. Lab Invest 1983; 49 (Suppl. 02) 208-15.
• 17 Shi Y, Pieniek M, Fard A, O BJ Mannion J, Zalewski A. Adventitial remodeling after coronary arterial injury. Circulation 1996; 93 (Suppl. 02) 340-8.
• 18 Strauss BH, Rabinovitch M. Adventitial fibroblasts. Defining a role in vessel wall emodeling. Am J Respir Cell Mol Biol 2000; 22: 1-3.
• 19 Mattsson E, Clowes AW. Current concepts in restenosis following balloon angiplasty. Trend Cardiovasc Med 1995; 5 (Suppl. 05) 200-4.
• 20 Fleser A, Leclere G. The current status of stentin – pathobiology. Trend Cardiovasc Med 1997; 7: 24-8.
• 21 Schwartz SM, Debloid D, Obrien ERM. The intima – soil for atherosclerosis and restenosis. Circ Res 1995; 77 (Suppl. 03) 455-65.
• 22 Bilder G, Wentz T, Leadley R, Amin D, Byan L, O’Conner B. et al. Restenosis following angioplasty in the swine coronary artery is inhibited by an orally active PDGF-receptor tyrosine kinase inhibitor, RPR101511A. Circulation 1999; 99 (Suppl. 25) 3292-9.
• 23 Myllarniemi M, Calderon L, Lemstrom K, Buchdunger E, Hayry P. Inhibition of platelet-derived growth factor receptor tyrosine kinase inhibits vascular smooth muscle cell migration and proliferation. FASEB J 1997; 11 (Suppl. 13) 1119-16.
• 24 Sirois MG, Simons M, Edelman ER. Antisense oligonucleotide inhibition of PDGFR-beta receptor subunit expression directs suppression of intimal thickening. Circulation 1997; 95: 669-76.
• 25 Reidy MA, Fingerle J, Lindner V. Factors controlling the development of arterial lesions after injury. Circulation 1992; 86 AIII III43-46.
• 26 Rutherford C, Martin W, Salame M, Carrier M, Anggard E, Ferns G. Substantial inhibition of neo-intimal response to balloon injury in the rat carotid artery using a combination of antibodies to platelet-derived growth factor-BB and basic fibroblast growth factor. Atherosclerosis 1997; 130 1, 2 45-51.
• 27 Kanzaki T, Tamura K, Takahashi K, Saito Y, Akikusa B, Oohashi H. et al. In vivo effect of TGF-beta 1 – enhanced intimal thickening by administration of TGF-beta 1 in rabbit arteries injured with a balloon catheter. Arterioscler Thromb Vasc Biol 1995; 15 (Suppl. 11) 1951-7.
• 28 Fingerle J, Muller RMK, Kuhn H, Pech M, Baumgartner HR. Mechanism of inhibition of neointimal formation by the angiotensin-converting enzyme inhibitor cilazapril – a study in balloon catheter-injured rat carotid arteries. Arterioscler Thromb Vasc Biol 1995; 15 (Suppl. 11) 1945-50.
• 29 Lehtonen JY, Horiuchi M, Daviet L, Akishita M, Dzau VJ. Activation of the de novo biosynethesis of sphingolipids mediates angiotensin II type 2 receptor-induced apoptosis. Journal of Biological Chemistry 1999; 274 (Suppl. 24) 16901-6.
• 30 Damiano BP, D’Andrea MR, de Garavilla L, Cheung W, Andrade-Gordon P. Increased expression of protease activated receptor-2 (PAR-2) in balloon-injured rat carotid artery. Thromb Haemost 1999; 81: 808-14.
• 31 D’Andrea MR DC, Santulli RJ, Andrade-Gordon P. Expression of protease-activated receptpors-1 and -2 in the tumor microenvironment of human carcinomas. American Journal of Pathology. 2001 In Press.
• 32 Liu Y, Wada R, Yamashita T, Mi Y, Deng CX, Hobson JP. et al. Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. [see comments]. J Clin Invest 200 106 (Suppl. 08) 951-61.
• 33 Ruef J, Meshel AS, Hu Z, Horaist C, Ballinger CA, Thompson LJ. et al. Flavopiridol inhibits smooth muscle cell proliferation in vitro and neointimal formation in vivo after carotid injury in the rat. Circulation 1999; 100 (Suppl. 06) 659-56.
• 34 Zempo N, Koyama N, Kenagy RD, Lea HJ, Clowes AW. Regulation of Vascular Smooth Muscle Cell Migration and Proliferation In Vitro and in Injured Rat Arteries by a Synthetic Matrix Metalloproteinase Inhibitor. Arteriosclerosis, Thrombosis & Vascular Biology 1996; 16 (Suppl. 01) 28-33.